Benzinga

MAY 13, 2022

22nd Century Group, Inc. million unregistered shares of common stock of the company. million unregistered shares of common stock of the company. Cowen served as an exclusive financial advisor to GVB. NASDAQ: XXII ) announced the acquisition of privately held GVB Biopharma. Deal Details.

Marketability 93

Marketability 93

Law 360 M&A

FEBRUARY 24, 2023

Canada's TD Bank Group said Friday it has received all regulatory approvals to complete its previously announced plan to buy financial services company Cowen Inc. billion and expects the deal to close March 1.

Banking 40

Banking 40

Law 360 M&A

OCTOBER 7, 2022

Financial services company Cowen Inc. and its board and chief executive officer were hit Friday with an investor's suit seeking to halt the company's proposed $1.3 billion acquisition by TD Bank until stockholders have enough information about the deal's finances to cast informed votes on the deal.

Banking 40

Banking Finance 40

Law 360 M&A

AUGUST 2, 2022

TD Bank Group will acquire financial services company Cowen Inc. billion in an all-cash transaction led by three law firms that positions its subsidiary TD Securities to boost its growth in the United States, the companies announced Tuesday.

Banking 40

Banking 40

Benzinga

NOVEMBER 29, 2023

29, 2023 (GLOBE NEWSWIRE) -- Proterra Inc (OTC: PTRAQ ) ("Proterra" or the "Company"), a leading innovator in commercial vehicle electrification technology, today announced that the Company has received final approval from the U.S. The Sale hearing for Phoenix Motor, Inc.'s BURLINGAME, Calif.,

Technology 40

Technology Equity Marketability 40

Benzinga

OCTOBER 19, 2023

19, 2023 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. Tourmaline") (NASDAQ: TRML ), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune diseases, today announced the completion of its previously announced merger with Talaris Therapeutics, Inc.

Marketability 45

Marketability 45

Benzinga

JUNE 22, 2023

8 million and approximately 21.3 % of the combined company BOSTON and NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. 8 million and approximately 21.3 % of the combined company BOSTON and NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc.

Dividends 40

Dividends Finance 40